Finally, the resistin receptor CAP1 was shown for the first time in the present study to be expressed across a large panel of breast cancer cell lines and primary human tumors, and that high CAP1 expression was associated with poor tumor characteristics and impaired prognosis among breast cancer patients. The gene discussed is CAP1; the disease is neoplasm.